Erratum: MY-T study: Symptom-based titration decisions when using testosterone nasal gel, Natesto® (Can Urol Assoc J (2019) 13:10 (301-6) DOI: 10.5489/cuaj.5662)

M. Durrani; N. Aldhaam; A. Elsayed; A. Christophe; Y. Fu; Q. Zhang; L. Cavuoto; A. Hussein; K. Guru

doi:10.5489/CUAJ.7054

Erratum: MY-T study: Symptom-based titration decisions when using testosterone nasal gel, Natesto^® (Can Urol Assoc J (2019) 13:10 (301-6) DOI: 10.5489/cuaj.5662)

M. Durrani
, N. Aldhaam
, A. Elsayed
, A. Christophe
, Y. Fu
, Q. Zhang
, L. Cavuoto
, A. Hussein
, K. Guru

Department of Industrial and Systems Engineering

University at Buffalo

Roswell Park Comprehensive Cancer Center
SUNY Buffalo

Research output: Contribution to journal › Comment/debate

Abstract

In the paper entitled, “MY-T study: Symptom-based titration decisions when using testosterone nasal gel, Natesto^®,” (Citation: Can Urol Assoc J 2019;13(10):301-6. http://dx.doi.org/10.5489/cuaj.5662), there were errors in Table 3, “Mean hematocrit values by visit and dose (safe population). CUAJ regrets the oversight and apologizes for any inconvenience. Visit https://cuaj.ca/index.php/journal/article/view/5662/4202 for a corrected version of the data, which is also included below. (Table Presented).

Original language	English
Pages (from-to)	E643
Journal	Canadian Urological Association Journal
Volume	14
Issue number	12
DOIs	https://doi.org/10.5489/CUAJ.7054
State	Published - Nov 23 2020

Access to Document

10.5489/CUAJ.7054

Cite this

Durrani, M., Aldhaam, N., Elsayed, A., Christophe, A., Fu, Y., Zhang, Q., Cavuoto, L., Hussein, A., & Guru, K. (2020). Erratum: MY-T study: Symptom-based titration decisions when using testosterone nasal gel, Natesto^® (Can Urol Assoc J (2019) 13:10 (301-6) DOI: 10.5489/cuaj.5662). Canadian Urological Association Journal, 14(12), E643. https://doi.org/10.5489/CUAJ.7054

@article{b11b865dab5c4cac8ec6ef488a284f0e,

title = "Erratum: MY-T study: Symptom-based titration decisions when using testosterone nasal gel, Natesto{\textregistered} (Can Urol Assoc J (2019) 13:10 (301-6) DOI: 10.5489/cuaj.5662)",

abstract = "In the paper entitled, “MY-T study: Symptom-based titration decisions when using testosterone nasal gel, Natesto{\textregistered},” (Citation: Can Urol Assoc J 2019;13(10):301-6. http://dx.doi.org/10.5489/cuaj.5662), there were errors in Table 3, “Mean hematocrit values by visit and dose (safe population). CUAJ regrets the oversight and apologizes for any inconvenience. Visit https://cuaj.ca/index.php/journal/article/view/5662/4202 for a corrected version of the data, which is also included below. (Table Presented).",

author = "M. Durrani and N. Aldhaam and A. Elsayed and A. Christophe and Y. Fu and Q. Zhang and L. Cavuoto and A. Hussein and K. Guru",

year = "2020",

month = nov,

day = "23",

doi = "10.5489/CUAJ.7054",

language = "English",

volume = "14",

pages = "E643",

journal = "Canadian Urological Association Journal",

issn = "1911-6470",

publisher = "Canadian Urological Association",

number = "12",

}

Durrani, M, Aldhaam, N, Elsayed, A, Christophe, A, Fu, Y, Zhang, Q, Cavuoto, L, Hussein, A & Guru, K 2020, 'Erratum: MY-T study: Symptom-based titration decisions when using testosterone nasal gel, Natesto^® (Can Urol Assoc J (2019) 13:10 (301-6) DOI: 10.5489/cuaj.5662)', Canadian Urological Association Journal, vol. 14, no. 12, pp. E643. https://doi.org/10.5489/CUAJ.7054

TY - JOUR

T1 - Erratum

T2 - MY-T study: Symptom-based titration decisions when using testosterone nasal gel, Natesto® (Can Urol Assoc J (2019) 13:10 (301-6) DOI: 10.5489/cuaj.5662)

AU - Durrani, M.

AU - Aldhaam, N.

AU - Elsayed, A.

AU - Christophe, A.

AU - Fu, Y.

AU - Zhang, Q.

AU - Cavuoto, L.

AU - Hussein, A.

AU - Guru, K.

PY - 2020/11/23

Y1 - 2020/11/23

N2 - In the paper entitled, “MY-T study: Symptom-based titration decisions when using testosterone nasal gel, Natesto®,” (Citation: Can Urol Assoc J 2019;13(10):301-6. http://dx.doi.org/10.5489/cuaj.5662), there were errors in Table 3, “Mean hematocrit values by visit and dose (safe population). CUAJ regrets the oversight and apologizes for any inconvenience. Visit https://cuaj.ca/index.php/journal/article/view/5662/4202 for a corrected version of the data, which is also included below. (Table Presented).

AB - In the paper entitled, “MY-T study: Symptom-based titration decisions when using testosterone nasal gel, Natesto®,” (Citation: Can Urol Assoc J 2019;13(10):301-6. http://dx.doi.org/10.5489/cuaj.5662), there were errors in Table 3, “Mean hematocrit values by visit and dose (safe population). CUAJ regrets the oversight and apologizes for any inconvenience. Visit https://cuaj.ca/index.php/journal/article/view/5662/4202 for a corrected version of the data, which is also included below. (Table Presented).

UR - https://www.scopus.com/pages/publications/85098132076

U2 - 10.5489/CUAJ.7054

DO - 10.5489/CUAJ.7054

M3 - Comment/debate

SN - 1911-6470

VL - 14

SP - E643

JO - Canadian Urological Association Journal

JF - Canadian Urological Association Journal

IS - 12

ER -

Erratum: MY-T study: Symptom-based titration decisions when using testosterone nasal gel, Natesto^® (Can Urol Assoc J (2019) 13:10 (301-6) DOI: 10.5489/cuaj.5662)

Abstract

Access to Document

Other files and links

Fingerprint

Cite this